The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Genesee BioMedical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Genesee BioMedical Inc (Genesee BioMedical) is a medical device company that provides medical and surgical instruments. The company offers heart valve repair products, MICS devices, pediatric retractors, retractors for cardiac surgery, robotic assisted devices, neonate retractors and accessories. Its heart valve repair products include annuloplasty rings and bands, adult curved sternal retractor, aortic tool kit, adult retractor, and minimally invasive retractor. Genesee BioMedical’s pediatric retractors comprise pediatric curved retractor and child curved retractor. The company serves medical, healthcare, and pharmaceutical sectors. Genesee BioMedical is headquartered in Denver, Colorado, the US.
The key metrics of Genesee BioMedical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Genesee BioMedical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Genesee BioMedical.
For a detailed understanding of the performance of Genesee BioMedical, buy the report here.